Published in J Clin Microbiol on March 07, 2007
The fitness cost of antibiotic resistance in Streptococcus pneumoniae: insight from the field. PLoS One (2012) 1.15
Polyclonal population structure of Streptococcus pneumoniae isolates in Spain carrying mef and mef plus erm(B). Antimicrob Agents Chemother (2008) 0.93
Pneumococcal surface protein A family types of Streptococcus pneumoniae from community-acquired pneumonia patients in Japan. Eur J Clin Microbiol Infect Dis (2007) 0.79
Development and evaluation of MALDI-TOF MS-based serotyping for Streptococcus pneumoniae. Eur J Clin Microbiol Infect Dis (2015) 0.78
Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol (1995) 88.05
Detection of erythromycin-resistant determinants by PCR. Antimicrob Agents Chemother (1996) 10.56
DNA fingerprinting of Streptococcus pneumoniae strains by pulsed-field gel electrophoresis. J Clin Microbiol (1993) 5.49
Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis (2003) 5.21
Failure of macrolide antibiotic treatment in patients with bacteremia due to erythromycin-resistant Streptococcus pneumoniae. Clin Infect Dis (2002) 3.48
Spread of drug-resistant Streptococcus pneumoniae in Asian countries: Asian Network for Surveillance of Resistant Pathogens (ANSORP) Study. Clin Infect Dis (1999) 2.74
Predicting antimicrobial resistance in invasive pneumococcal infections. Clin Infect Dis (2005) 2.59
Macrolide resistance among invasive Streptococcus pneumoniae isolates. JAMA (2001) 2.40
Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis (2001) 2.39
Increasing prevalence of antimicrobial resistance among isolates of Streptococcus pneumoniae from the PROTEKT surveillance study, and compatative in vitro activity of the ketolide, telithromycin. J Antimicrob Chemother (2002) 2.30
The Alexander Project 1996-1997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections. J Antimicrob Chemother (2000) 2.27
Resistance to macrolides and related antibiotics in Streptococcus pneumoniae. Antimicrob Agents Chemother (2002) 2.17
Clinical relevance of macrolide-resistant Streptococcus pneumoniae for community-acquired pneumonia. Clin Infect Dis (2002) 1.98
Drug-resistant pneumococcal pneumonia: clinical relevance and related factors. Clin Infect Dis (2004) 1.85
Erythromycin and common cold in COPD. Chest (2001) 1.78
Emergence and spread of Streptococcus pneumoniae with erm(B) and mef(A) resistance. Emerg Infect Dis (2005) 1.74
The emergence of Streptococcus pneumoniae resistant to macrolide antimicrobial agents: a 6-year population-based assessment. J Infect Dis (2000) 1.69
Clinical resolution in patients with suspicion of ventilator-associated pneumonia: a cohort study comparing patients with and without acute respiratory distress syndrome. Crit Care Med (2005) 1.60
C-reactive protein as a marker of ventilator-associated pneumonia resolution: a pilot study. Eur Respir J (2005) 1.49
Evolution of erythromycin-resistant Streptococcus pneumoniae from Asian countries that contains erm(B) and mef(A) genes. J Infect Dis (2004) 1.41
Intrapulmonary pharmacokinetics of azithromycin in healthy volunteers given five oral doses. Antimicrob Agents Chemother (1996) 1.39
Emergence of invasive erythromycin-resistant Streptococcus pneumoniae strains in Portugal: contribution and phylogenetic relatedness of serotype 14. J Antimicrob Chemother (2004) 1.21
In vitro activities of new ketolide, telithromycin, and eight other macrolide antibiotics against Streptococcus pneumoniae having mefA and ermB genes that mediate macrolide resistance. J Infect Chemother (2003) 1.16
Activities of telithromycin against 13,874 Streptococcus pneumoniae isolates collected between 1999 and 2003. Antimicrob Agents Chemother (2004) 1.12
Demographic analysis of antimicrobial resistance among Streptococcus pneumoniae: worldwide results from PROTEKT 1999-2000. Int J Infect Dis (2005) 1.09
Macrolide activities beyond their antimicrobial effects: macrolides in diffuse panbronchiolitis and cystic fibrosis. J Antimicrob Chemother (2004) 1.08
High-level telithromycin resistance in laboratory-generated mutants of Streptococcus pneumoniae. J Antimicrob Chemother (2003) 1.05
PROTEKT 1999-2000: a multicentre study of the antibiotic susceptibility of respiratory tract pathogens in Hong Kong, Japan and South Korea. Int J Antimicrob Agents (2004) 1.03
A review of clinical failures associated with macrolide-resistant Streptococcus pneumoniae. Int J Antimicrob Agents (2004) 0.98
Clinical outcomes of pneumococcal pneumonia caused by antibiotic-resistant strains in asian countries: a study by the Asian Network for Surveillance of Resistant Pathogens. Clin Infect Dis (2004) 0.90
Clonal dissemination of macrolide-resistant and penicillin-susceptible serotype 3 and penicillin-resistant Taiwan 19F-14 and 23F-15 Streptococcus pneumoniae isolates in Japan: a pilot surveillance study. J Clin Microbiol (2005) 0.89
High frequency of erythromycin A resistance and distribution of mefE and ermB genes in clinical isolates of Streptococcus pneumoniae in Japan. J Infect Chemother (2002) 0.87
The clinical significance of macrolide-resistant Streptococcus pneumoniae: it's all relative. Clin Infect Dis (2003) 0.86
Infections caused by erythromycin-resistant Streptococcus pneumoniae: incidence, risk factors, and response to therapy in a prospective study. Clin Infect Dis (1995) 0.85
Hospital-related outbreak of infection with multidrug-resistant Streptococcus pneumoniae in the Netherlands. J Hosp Infect (1999) 0.84
Macrolide resistance of Streptococcus pneumoniae isolated during long-term macrolide therapy: difference between erythromycin and clarithromycin. J Infect Chemother (2005) 0.80
Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol (2012) 7.39
Phase III study, V-15-32, of gefitinib versus docetaxel in previously treated Japanese patients with non-small-cell lung cancer. J Clin Oncol (2008) 3.27
Association between sleep apnea, sleep duration, and serum lipid profile in an urban, male, working population in Japan. Chest (2013) 3.23
Relationship of airway wall thickness to airway sensitivity and airway reactivity in asthma. Am J Respir Crit Care Med (2003) 2.32
Childhood neglect is associated with reduced corpus callosum area. Biol Psychiatry (2004) 2.26
A randomized, placebo-controlled trial of acupuncture in patients with chronic obstructive pulmonary disease (COPD): the COPD-acupuncture trial (CAT). Arch Intern Med (2012) 2.20
How sensitive are epidermal growth factor receptor-tyrosine kinase inhibitors for squamous cell carcinoma of the lung harboring EGFR gene-sensitive mutations? J Thorac Oncol (2013) 2.11
Genome-wide association study identifies three new susceptibility loci for adult asthma in the Japanese population. Nat Genet (2011) 2.10
Surgical treatment of local recurrence after stereotactic body radiotherapy for primary and metastatic lung cancers. J Thorac Oncol (2010) 2.08
High-resolution multi-dimensional NMR spectroscopy of proteins in human cells. Nature (2009) 2.06
Impact of exacerbations on emphysema progression in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2011) 2.03
Treatment with methotrexate and low-dose corticosteroids in sarcoidosis patients with cardiac lesions. Intern Med (2014) 2.00
Characterization of group C and G streptococcal strains that cause streptococcal toxic shock syndrome. J Clin Microbiol (2004) 2.00
Mutations in the SLC34A2 gene are associated with pulmonary alveolar microlithiasis. Am J Respir Crit Care Med (2006) 1.98
Quantitative assessment of airway remodeling using high-resolution CT. Chest (2002) 1.79
Asymmetrical allocation of NMDA receptor epsilon2 subunits in hippocampal circuitry. Science (2003) 1.77
Risk and severity of COPD is associated with the group-specific component of serum globulin 1F allele. Chest (2004) 1.77
Serodiagnosis of Mycobacterium avium-complex pulmonary disease using an enzyme immunoassay kit. Am J Respir Crit Care Med (2007) 1.75
Protein structure determination in living cells by in-cell NMR spectroscopy. Nature (2009) 1.71
Desert dust exposure is associated with increased risk of asthma hospitalization in children. Am J Respir Crit Care Med (2010) 1.69
Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis. Chest (2007) 1.66
Accidental exposures to blood and body fluid in the operation room and the issue of underreporting. Am J Infect Control (2009) 1.66
CT scan findings of emphysema predict mortality in COPD. Chest (2010) 1.57
Effect of short-term treatment with inhaled corticosteroid on airway wall thickening in asthma. Am J Med (2004) 1.53
Long-term clinical course of a patient with anti PL-12 antibody accompanied by interstitial pneumonia and severe pulmonary hypertension. Intern Med (2005) 1.52
Matrix metalloproteinase-9 promoter polymorphism associated with upper lung dominant emphysema. Am J Respir Crit Care Med (2005) 1.52
Purpuric drug eruption possibly due to gefinitib (Iressa). Int J Dermatol (2005) 1.51
Specific IgE response to trichophyton and asthma severity. Chest (2009) 1.49
Hot spring bath and Legionella pneumonia: an association confirmed by genomic identification. Intern Med (2002) 1.48
Corrected QT dispersion and cardiac sympathetic function in patients with obstructive sleep apnea-hypopnea syndrome. Chest (2004) 1.47
Diabetes insipidus from neurosarcoidosis: long-term follow-up for more than eight years. Intern Med (2004) 1.46
Falls in blood pressure in patients with obstructive sleep apnoea after long-term nasal continuous positive airway pressure treatment. J Hypertens (2006) 1.46
The use of non-invasive ventilation for life-threatening asthma attacks: Changes in the need for intubation. Respirology (2010) 1.44
Importance of ventilator mode in long-term noninvasive positive pressure ventilation. Respir Med (2009) 1.43
Cerebrospinal fluid concentration of gefitinib and erlotinib in patients with non-small cell lung cancer. Cancer Chemother Pharmacol (2012) 1.43
Polymorphisms of B7 (CD80 and CD86) genes do not affect disease susceptibility to sarcoidosis. Respiration (2005) 1.42
Videothoracoscopy-assisted surgical lung biopsy for interstitial lung diseases. Gen Thorac Cardiovasc Surg (2014) 1.41
Detection of herpes viruses by multiplex and real-time polymerase chain reaction in bronchoalveolar lavage fluid of patients with acute lung injury or acute respiratory distress syndrome. Respiration (2013) 1.40
Noninvasive ventilation improves the outcome of pulmonary complications after liver resection. Intern Med (2010) 1.40
Pulmonary hemorrhage induced by epileptic seizure. Heart Lung (2011) 1.39
Serum procalcitonin is a valuable diagnostic marker in acute exacerbation of interstitial pneumonia. Respirology (2013) 1.37
Cerebrospinal fluid concentration of erlotinib and its active metabolite OSI-420 in patients with central nervous system metastases of non-small cell lung cancer. J Thorac Oncol (2010) 1.34
Treatment of pulmonary epithelioid hemangioendothelioma with bevacizumab. J Thorac Oncol (2010) 1.32
Relationship between pulmonary emphysema and osteoporosis assessed by CT in patients with COPD. Chest (2008) 1.28
Prostaglandin F(2alpha) receptor signaling facilitates bleomycin-induced pulmonary fibrosis independently of transforming growth factor-beta. Nat Med (2009) 1.28
Pulmonary manifestations of primary Sjogren's syndrome: a clinical, radiologic, and pathologic study. Am J Respir Crit Care Med (2004) 1.27
Good clinical response to gefitinib in a non-small cell lung cancer patient harboring a rare somatic epidermal growth factor gene point mutation; codon 768 AGC > ATC in exon 20 (S768I). Jpn J Clin Oncol (2010) 1.26
Emergence and spread of B2-ST131-O25b, B2-ST131-O16 and D-ST405 clonal groups among extended-spectrum-β-lactamase-producing Escherichia coli in Japan. J Antimicrob Chemother (2012) 1.24
Abnormal swallowing reflex and COPD exacerbations. Chest (2009) 1.22
Comparative study of high-resolution CT findings between autoimmune and secondary pulmonary alveolar proteinosis. Chest (2009) 1.22
Ectopic production of MDA-7/IL-24 inhibits invasion and migration of human lung cancer cells. Mol Ther (2004) 1.19
Repeated instruction on inhalation technique improves adherence to the therapeutic regimen in asthma. J Asthma (2010) 1.18
Longitudinal deteriorations in patient reported outcomes in patients with COPD. Respir Med (2006) 1.18
Sensitive and specific new enzyme-linked immunosorbent assay for N-ERC/mesothelin increases its potential as a useful serum tumor marker for mesothelioma. Clin Cancer Res (2008) 1.17
Role of non-invasive ventilation in managing life-threatening acute exacerbation of interstitial pneumonia. Intern Med (2010) 1.16
Intravenous peramivir for treatment of influenza A and B virus infection in high-risk patients. Antimicrob Agents Chemother (2011) 1.16
Target-cell-specific left-right asymmetry of NMDA receptor content in schaffer collateral synapses in epsilon1/NR2A knock-out mice. J Neurosci (2005) 1.15
A novel apoptosis-inducing protein from Helicobacter pylori. Mol Microbiol (2003) 1.14
Expression of breast cancer resistance protein is associated with a poor clinical outcome in patients with small-cell lung cancer. Lung Cancer (2008) 1.14
The Japanese Respiratory Society guidelines for management of cough. Respirology (2006) 1.13
Phase III randomized, double-blind study comparing single-dose intravenous peramivir with oral oseltamivir in patients with seasonal influenza virus infection. Antimicrob Agents Chemother (2011) 1.12
Global Escherichia coli Sequence Type 131 Clade with blaCTX-M-27 Gene. Emerg Infect Dis (2016) 1.12
Essential role of interleukin-12 (IL-12) and IL-18 for gamma interferon production induced by listeriolysin O in mouse spleen cells. Infect Immun (2002) 1.12
National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin. J Antimicrob Chemother (2003) 1.12
Optimal cutoff level of breath carbon monoxide for assessing smoking status in patients with asthma and COPD. Chest (2003) 1.11
Efficacy of increased-dose erlotinib for central nervous system metastases in non-small cell lung cancer patients with epidermal growth factor receptor mutation. Cancer Chemother Pharmacol (2011) 1.11
A long-term study of sharps injuries among health care workers in Japan. Am J Infect Control (2007) 1.11
Incidence of pulmonary hypertension and its clinical relevance in patients with sarcoidosis. Chest (2006) 1.10
In-cell NMR spectroscopy of proteins inside Xenopus laevis oocytes. J Biomol NMR (2006) 1.10
A case of isolated IgG4-related interstitial pneumonia: a new consideration for the cause of idiopathic nonspecific interstitial pneumonia. Chest (2012) 1.09
Prognostic value of reduced left ventricular ejection fraction at start of hemodialysis therapy on cardiovascular and all-cause mortality in end-stage renal disease patients. Clin J Am Soc Nephrol (2010) 1.09
The safety and efficacy of paclitaxel and carboplatin with or without bevacizumab for treating patients with advanced nonsquamous non-small cell lung cancer with interstitial lung disease. Cancer Chemother Pharmacol (2014) 1.08
Peritonitis is still an important factor for withdrawal from peritoneal dialysis therapy in the Tokai area of Japan. Clin Exp Nephrol (2011) 1.08
The plasminogen activation system reduces fibrosis in the lung by a hepatocyte growth factor-dependent mechanism. Am J Pathol (2004) 1.08